Why the study?
Mouse GPVI does not promote platelet activation on immobilized fibrinogen unlike human GPVI, prompting investigation into the consequences of this absence on thrombosis regulation across species.
Population
Mouse and human thrombus models
Comparison
Absence vs presence of GPVI/fibrinogen-mediated platelet activation in mouse vs human systems
Design
Comparative experimental preclinical study
Key result
Unlike human GPVI, mouse GPVI does not promote platelet activation on immobilized fibrinogen, highlighting a critical species difference in experimental thrombosis models.
Authors
Loading...
Mouse GPVI models may not translate to human fibrinogen responses; leaves open GPVI's role in clinical thrombosis.
This study highlights critical species differences in GPVI-mediated platelet activation between mice and humans, which is important for interpreting experimental thrombosis models.
Janus‐Bell et al. (2020) studied Thrombosis. GPVI/fibrinogen-mediated platelet activation vs. Human system was evaluated on Regulation of thrombosis. Unlike human GPVI, mouse GPVI does not promote platelet activation on immobilized fibrinogen, highlighting a critical species difference in experimental thrombosis models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: